JPWO2022244876A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022244876A5 JPWO2022244876A5 JP2023522741A JP2023522741A JPWO2022244876A5 JP WO2022244876 A5 JPWO2022244876 A5 JP WO2022244876A5 JP 2023522741 A JP2023522741 A JP 2023522741A JP 2023522741 A JP2023522741 A JP 2023522741A JP WO2022244876 A5 JPWO2022244876 A5 JP WO2022244876A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- sequence
- seq
- cell receptor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021085406 | 2021-05-20 | ||
| PCT/JP2022/020990 WO2022244876A1 (ja) | 2021-05-20 | 2022-05-20 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022244876A1 JPWO2022244876A1 (cg-RX-API-DMAC7.html) | 2022-11-24 |
| JPWO2022244876A5 true JPWO2022244876A5 (cg-RX-API-DMAC7.html) | 2025-04-17 |
Family
ID=84141709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522741A Pending JPWO2022244876A1 (cg-RX-API-DMAC7.html) | 2021-05-20 | 2022-05-20 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022244876A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022244876A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024163292A1 (en) * | 2023-01-30 | 2024-08-08 | Board Of Regents, The University Of Texas System | T-cell receptors targeting her2 and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011145615A1 (ja) * | 2010-05-18 | 2011-11-24 | タカラバイオ株式会社 | 多能性幹細胞の製造のための核酸 |
| JP5984113B2 (ja) * | 2012-06-11 | 2016-09-06 | 学校法人慶應義塾 | がん免疫療法 |
| GB201717578D0 (en) * | 2017-10-26 | 2017-12-13 | Univ College Cardiff Consultants Ltd | Novel T-cell receptor |
| CN112912391B (zh) * | 2018-10-25 | 2026-07-03 | 昆士兰医学研究所理事会 | T细胞受体及其用途 |
| GB2613715B (en) * | 2019-02-20 | 2023-12-06 | Fred Hutchinson Cancer Center | Binding proteins specific for RAS neoantigens and uses thereof |
-
2022
- 2022-05-20 WO PCT/JP2022/020990 patent/WO2022244876A1/ja not_active Ceased
- 2022-05-20 JP JP2023522741A patent/JPWO2022244876A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240390480A1 (en) | Nucleic acid vaccines | |
| US20180236044A1 (en) | Methods and compositions for rna-guided treatment of hiv infection | |
| AU2025204711A1 (en) | Shared neoantigens | |
| ES2545885T3 (es) | Eliminación de respuestas inmunitarias contra vectores virales | |
| JP2022031687A (ja) | リン酸塩輸送阻害のための化合物及び方法 | |
| JP2019506156A (ja) | Hiv感染症のrna誘導型治療のための方法及び組成物 | |
| JP2015522264A5 (cg-RX-API-DMAC7.html) | ||
| KR20180096591A (ko) | 광범위 인플루엔자 바이러스 백신 | |
| KR20180096592A (ko) | 호흡기 세포융합 바이러스 백신 | |
| JP2012500001A5 (cg-RX-API-DMAC7.html) | ||
| CN101863971A (zh) | 转移素衍生物及其用途 | |
| JP2008525033A5 (cg-RX-API-DMAC7.html) | ||
| JP2015510393A5 (cg-RX-API-DMAC7.html) | ||
| JP2019502683A (ja) | 癌治療のための併用薬 | |
| US11666664B2 (en) | Self assembling molecules for targeted drug delivery | |
| JP2024511131A5 (cg-RX-API-DMAC7.html) | ||
| US10988522B2 (en) | Proteolically resistant cyclotides with angiotensin 1-7 like activity | |
| JP2024542995A5 (cg-RX-API-DMAC7.html) | ||
| US20190269711A1 (en) | Methods of treating cancer | |
| JP2024503091A5 (cg-RX-API-DMAC7.html) | ||
| RU2012146542A (ru) | Способ ингибирования репликации вич в клетках млекопитающих и у людей | |
| KR20150039259A (ko) | siRNA 전달을 위한 재조합 단백질 및 이를 포함하는 조성물 | |
| JP2024504467A5 (cg-RX-API-DMAC7.html) | ||
| EP3271020B1 (en) | Reversal of latency of retroviruses with a galectin protein | |
| JP2008531463A5 (cg-RX-API-DMAC7.html) |